Targeting phosphate metabolism in CKD to improve survival
Disordered phosphate metabolism is associated with increased risk of death in ESRD, CKD, following kidney transplantation, and in the general population. FGF23 is an early marker of disordered phosphate metabolism that could be used to identify participants for an RCT in which one or a combination of phosphate binders, dietary manipulation or niacin could be used versus placebo to examine impact on CKD progression and ...more »
Disordered phosphate metabolism is associated with increased risk of death in ESRD, CKD, following kidney transplantation, and in the general population. FGF23 is an early marker of disordered phosphate metabolism that could be used to identify participants for an RCT in which one or a combination of phosphate binders, dietary manipulation or niacin could be used versus placebo to examine impact on CKD progression and mortality.
« less full details »

